Ionizing radiation is a non-specific but highly effective way to kill malignant cells. However,
tumor recurrence sustained by a minor fraction of surviving tumor cells is a commonplace …

Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide; its incidence
is increasing in the United States. Depending on disease extent and underlying liver status …

Purpose To quantitatively evaluate published experiences with hepatic stereotactic body
radiation therapy (SBRT), to determine local control rates after treatment of primary and …

Objectives To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of hepatocellular carcinoma (HCC) unsuitable for standard loco …

Purpose An analysis was performed on patients enrolled in a phase 1-2 trial using
stereotactic body radiation therapy for hepatocellular carcinoma evaluating variables …

The International Commission on Radiation Units and Measurements - Hans-Georg Menzel,
2012 Skip to main content Scheduled maintenance on Monday, November 20th, with …

Purpose Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has
been evaluated in several recent studies. The CyberKnife® is an SBRT system that allows …

The integration of new technologies has raised an interest in liver tumor radiotherapy, with
literature evolving to support its efficacy. These advances, particularly stereotactic body …

Hepatocellular Carcinoma (HCC) is one of the most common cancers and a leading cause
of cancer related death worldwide. Until recently, systemic therapy for advanced HCC …

The role for local ablative therapies in the management paradigm of oligometastatic liver
disease is increasing. The evidence base supporting the use of stereotactic body …